Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor

Citation
Y. Sowa et al., Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor, CANCER RES, 59(17), 1999, pp. 4266-4270
Citations number
42
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
59
Issue
17
Year of publication
1999
Pages
4266 - 4270
Database
ISI
SICI code
0008-5472(19990901)59:17<4266:SBNSMT>2.0.ZU;2-N
Abstract
We previously reported that both sodium butyrate and trichostatin A (TSA), both of which are known as inhibitors of histone deacetylase, arrest human tumor cells at G(1) and G(2)-M and activate the cyclin-dependent kinase inh ibitor, the p21/WAF1/Cip1 gene promoter, through the Spl sites. In this stu dy, we identified Sp1 and Sp3 as major factors binding to the Spl sites of the p21/WAF1/Cip1 promoter in MG63 cells through electrophoretic mobility s hift assays and showed that TSA treatment did not change their binding acti vities. However, GAL4-Sp3 but not GAL4-Sp1 fusion protein supported the TSA -mediated gene induction from a luciferase reporter plasmid driven by five GAL4 DNA-binding sites. Moreover, the ectopic expression of dominant negati ve Sp3 repressed the enhancement by TSA of the p21/WAF1/Cip1 promoter and S pl site-driven promoter. Taken together, these results suggest that histone deacetylase inhibitor up-regulates p21/WAF1/Cip1 transcription by Sp3 but not by Sp1.